Introduction
Delayed cerebral ischemia (DCI) is a major factor in morbidity and mortality after aneurysmal subarachnoid hemorrhage (SAH). Numerous studies have reported various factors for identifying patients at risk of developing DCI. General consensus was not established and further studies are needed. 1, 2 Hyponatremia occurs in 30 to 50% of patients with SAH. [3] [4] [5] The etiology of hyponatremia is still unclear, but it is probably mediated by hypothalamic injury secondary to SAH.
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The aim of our study was to examine the clinical influence of different parameters of metabolic disbalance on emergence of DCI and poor outcome. Any history of arterial hypertension and smoking habits were recorded on admission. Arterial hypertension was defined as the use of antihypertensive therapy last 3 months before SAH.
Patients and Methods
Level of sodium, magnesium, and white blood cells count in the blood was assessed every 12 hours. Duration of hyponatremia, leukocytosis, and hypomagnesemia considered clinically significant was at least 24 hours. Hyponatremia was d ef i n e d a s s e r um s o d i u m l evel < 1 3 5 m m o l / L , hypomagnesemia as serum magnesium level < 0.70 mmol/L and leukocytosis as serum leukocyte count > 12 Â 10 9 /L occurring at any point in time during the first 10 days after SAH. Patients were classified as febrile if body temperature ! 37.8°C was documented on at least two daily measurements.
All patients underwent noncontrast CT scan 9 AE 2 days after SAH. DCI was defined as one or more of a new focal neurological deficit, decline for two or more points on the mGCS scale or new hypodensities on CT scan not visible on admission or postoperative scan, not associated with initial hemorrhage, an intracerebral hematoma, placement of a ventricular catheter, metabolic disturbance, infection, or hypoxia. Cerebral ischemia was verified with CT scan by a study independent neuroradiologist. The outcome was assessed at 6 months after aneurysmal rupture with an extended Glasgow Outcome scale (eGOS). 20 Poor outcome was defined as 1-4 points on eGOS scale.
Statistical Analysis
For statistical analysis SPSS 20.0 was used. Differences between the groups were analyzed by Student t-test for normal distribution data and the Mann-Whitney U-test for data without normal distribution. For nonparametric data, the chi-square test was used. Logistic regression model was used to evaluate the impact of nondependent variables on DCI and poor outcome.
Results
The study included 68 patients with aneurysmal SAH. Positive finding of DCI was found in 33 patients (48%).
►Table 1 shows the inf luence of demographic characteristics, neurological status, smoking, and hypertension on development of DCI. In the group of patients with DCI, there was significantly higher WFNS score than in the group without delayed ischemia. Arterial hypertension in medical history has been shown to have significant impact on the development of DCI. Statistically significant differences were obtained for length of stay in the intensive care unit (p ¼ 0.001) and on hospital ward (p ¼ 0.025) between patients with and without DCI.
Nine patients were excluded because of the fever of infectious origin (positive microbiological testing).
►Table 2 shows the influence of fever, leukocytosis, hyponatremia, and hypomagnesemia on the development of DCI.
Statistically significant difference between DCI and DCI absent groups was obtained for hyponatremia and leukocytosis.
Logistic regression model showed significant impact of hyponatremia (p ¼ 0.036; OR ¼ 4.08; 95% CI ¼ 1.09-15.26) on the development of DCI.
Six months outcome on eGOS scale was 4.27 AE 2.42 in the group with DCI and 5.83 AE 2.32 in the group without DCI (p ¼ 0.004).
Overall, 15 patients died, while two had severe neurological damage. A good outcome (5-8 points on eGOS scale) was achieved in 51 patients.
►Table 3 shows the inf luence of demographic characteristics, neurological status, smoking, and arterial hypertension in the development of poor outcome.
In the group of patients with poor outcome, WFNS score was significantly higher than in the group with good outcome. Arterial hypertension also had a significant impact on the development of poor outcome. ►Table 4 shows the influence of fever, leukocytosis, hyponatremia, and hypomagnesemia on poor outcome. Statistically significant differences were obtained for hyponatremia and leukocytosis.
Logistic regression model has shown significant impact of hyponatremia (p ¼ 0.034; OR ¼ 5.11; 95% CI ¼ 1.13-23.14) on poor outcome.
Discussion
This study undertaken over 2 years and included 68 patients with SAH.
Hyponatremia after SAH is present in 28 to 55% of patients. We got similar results (38%). These results significantly overlap our retrospective study (2010) with 39% of patients with hyponatremia. 3, 5, 21 Laboratory control of the serum and urine osmolarity, sodium in urine and central venous pressure were standard measures in prevention of fluid restriction, maintenance of euvolemia, and therapy guide for daily fluid intake in the case of hyponatremia. Hypertonic saline solution (3%) was used to correct hyponatremia below 130 mmol/L or if it continued for more than 36 hours.
Focus of the study was a possible role of hyponatremia in prediction of cerebral ischemia and poor outcome. Our research from 2011 showed a positive correlation between hyponatremia and vasospasm, but in the context of clinical symptoms of DCI. 5 By comparing time of occurrence of hyponatremia and DCI (decrease of serum sodium level between 7th and 10th day, when we had the most of neurological complications) we did not get statistically significant correlation, which contradicts the results of Ramachandraiah and Chandy. 22 The cause of these differences could possibly be explained by designs of the following studies: they used sodium level below 135 or 4 mmol/L decrease from admission level as referent values. A significant difference of the outcome according to eGOS scale confirms the results of study of Saleh et al and our results from 2011. 5, 10 We obtained 53% of patients with hypomagnesemia, which is much more than van den Bergh (38%), Dhar and Diringer (2008) showed correlation between some systemic inflammatory response syndrome parameters (SIRS) and DCI. 23 [15] [16] [17] These studies used level of 15 Â 10 9 as reference, but we used 12 Â 10 9 because that value is the diagnostic limit for SIRS. Because of that, we had 57% of patients with leukocytosis in our study, and we have shown a statistically significant correlation between leukocytosis and cerebral ischemia and negative outcome. Comparing leukocytosis in the first 3 days after rupture, we got difference between the groups but not statistically significant. Our results show the potential benefit of 12 Â 10 9 limit, but new researches with greater number of participants are needed to give the right answer. Although multivariate analysis did not show predictive significance of leukocytosis our results confirmed potential of it, and 41 to 72% of patients with SAH had increased body temperature. Douds et al (2012) show a significant correlation between fever and symptomatic vasospasm and poor outcome. 18, 19, 24 These studies used body temperature between 37.5°C and 38.3°C as a limit of fever. None of the studies investigated this subject made a difference between fever of infectious and noninfectious origin. 18, 19, 24 Our goal was to determine the relationship between fever of noninfectious genesis between day 4 and day 9 following the rupture and DCI or poor outcome. This fever is an important part of systemic inflammatory response in this period in patients with signs of DCI. We obtained 54% of patients with noninfectious fever, although other studies had. 33 to 55%. 18, 19 More patients with fever in our study can be explained by different study design and different fever limit. Our results do not show significant correlation between fever of noninfectious genesis and DCI and poor outcome. Studies of Douds et al and Oliveira-Filho et al had no proper distinction between infectious and noninfectious fever, and Naidech et al had different methodology 18, 19, 24 that would explain the differences with our results.
We are aware that this study has several limitations. The real problem is the relatively small number of patients. This is a consequence of incidence of SAH in our hospital and exclusion of patients of level V of WFNS scale from the study. Relatively small number of patients did not let us to define existence of time connection (when precisely hyponatremia or leukocytosis precede DCI).
Conclusion
These results are still very interesting, implying a clear benefit of hyponatremia above and leukocytosis as additional predictors of developing DCI. We consider that daily monitoring of serum sodium and leukocytes level in the early course of SAH treatment can contribute to identifying patients with high risk of neurological complications and poor outcome and bring potential benefit in treatment protocols. 
